The migratory behaviour of dendritic cells (DC) is tightly linked to their differentiation state. Precursor DC constitutively repopulate normal tissues from the bloodstream, and are recruited in elevated numbers to sites of inflammation. Whilst maturing in response to antigenic stimulation, DC acquire the capability to enter lymph nodes via afferent lymphatic vessels, thus facilitating their presentation of antigen to naïve T cells. Peripheral blood monocytes constitute a second DC precursor population, which during an inflammatory response are recruited to the affected site where some differentiate into functional DC. The availability of separate DC precursor populations is thought to be significant for the character, amplification and perpetuation of the resultant immune response. In addition, the balance between steady-state trafficking of incompletely activated DC bearing self-antigens from the periphery, and the migration of fully mature DC from inflammatory sites into lymph nodes might have profound effects upon tolerance induction and activation of T cells, respectively.
Introduction
Dendritic cells (DC) are professional antigen-presenting cells (APC), capable of both priming an immune response, and efficiently stimulating memory responses. [1] [2] [3] In the past there has been much confusion over the classification of DC into subclasses; however, recent evidence suggests that in both mice and men there exist at least two major subsets of DC, namely myeloid-related (MDC) and plasmacytoid DC (PDC). Whereas MDC are the classical T cell priming subset, the function of PDC is less clear, although they might play an important role in the body's defence against pathogens. 4 In addition, conflicting evidence exists regarding those DC that express CD8α in the mouse, the so-called 'lymphoid' DC. Whereas CD8α + DC were thought to derive from a common lymphoid progenitor and induce tolerance 5, 6 more recent work suggests that these cells derive from MDC during maturation. [7] [8] [9] Dendritic cells are closely related to other cells of the myeloid lineage, in particular monocytes and macrophages ( Fig. 1 ). Unlike DC, however, monocytes, macrophages and other APC such as B cells are poor stimulators of naïve T cells. 1 Constitutively distributed throughout most tissues of the body in small numbers, DC are particularly localized to those sites that comprise the body's external barrier, i.e. the skin and mucosal surfaces. In peripheral tissues, DC exist in an immature form, efficient at taking up and processing antigens. 10 Once activated by signals that indicate a threat to the body's integrity, such as contact with microbial products or proinflammatory cytokines, DC undergo maturation into competent APC, bearing high levels of MHC and costimulatory molecules. 1, 2 An important question for the understanding of DC biology is how DC populate the periphery in homeostasis, and how they are recruited in inflammation. Myeloid-related dendritic cells enter the bloodstream from bone marrow and circulate as precursor/immature DC capable of the slow constitutive migration required for maintenance of resident tissue populations. 1 In inflammatory circumstances endothelial adhesion molecules and chemokines are up-regulated, facilitating efficient recruitment of circulating DC to the affected site. 11 Upon maturation, DC reprogram their repertoire of adhesion receptors 12, 13 and migrate to lymph nodes, where they obtain access to the naïve T cell population. 14, 15 The lineage relationship and migratory pathways of PDC are less well understood. Plasmacytoid dendritic cells circulate in peripheral blood in precursor form, and comprise a significant leucocyte population in most secondary lymphoid organs despite their relative absence in non-lymphoid organs. 4 Interestingly, PDC can be found in substantial numbers in some inflammatory conditions, such as rheumatoid arthritis (LL Cavanagh and R Thomas unpubl. data) and certain lymphoproliferative diseases. 16 Since DC are a central component of any immune response, both under physiologic and pathologic conditions, detailed characterization of their migratory properties may be essential for the development of future therapeutic strategies against cancer or autoimmune diseases. Here we outline our current understanding of the trafficking pathways of DC and their precursors to normal and diseased tissues, and discuss its potential role in immunoregulation.
Lineage relationship of dendritic cells and monocytes

Myeloid-related DC
Myeloid-related DC comprise the 'classical' APC population of the immune system. 3, 17 Human DC consist of a fairly uniform population, while in mice, a subset of 'lymphoid' DC is identified based on expression of CD8α, and localization in T cell areas of secondary lymphoid organs. [18] [19] [20] Conflicting data exist as to whether 'lymphoid' DC constitute a separate DC lineage. [21] [22] [23] However, recent studies have demonstrated that both CD8α -and CD8α + DC may arise from a single common myeloid progenitor, which circulates in the blood as a CD11c + MHC-II -precursor population. 7, 24 Thus, it is now thought that at least a fraction, if not all, of the CD8α + DC population represents a distinct differentiation state of CD8α -MDC. [7] [8] [9] 24 As immature cells, MDC possess a high capacity for the uptake of antigens via phagocytosis, receptor-mediated pinocytosis and fluid-phase macropinocytsis. 18 A functional dichotomy may exist between murine DC subsets: CD8α -DC seem to induce a Th2-biased response, whereas CD8α + DC produce interleukin (IL)-12 required for Th1 polarization, and endocytose apoptotic cells, which may explain their competence for cross presentation. [25] [26] [27] [28] In the blood, DC express a wide range of adhesion molecules, facilitating their migration into various tissues (Table 1) . Certain organ-specific phenotypic and possible functional differences exist in resident MDC that populate various peripheral tissues. Most notably, epidermal Langerhans cells (LC) express CD1a in humans, as well as characteristic cytoplasmic Birbeck granules, and the associated langerin molecule. 29, 30 Langerhans cells also express the chemokine receptor CCR6, which might play a role in their unique localization to the epidermis. 31 However, whether these specific features bear functional relevance has yet to be determined.
Plasmacytoid DC
Cells containing abundant rough endoplasmic reticulum that resided in T cell areas of reactive lymph nodes were initially misidentified as plasmacytoid T cells. 32 Detection of myelomonocytic lineage marker expression led to their reclassification as plasmacytoid monocytes. 33 More recently, studies on the functional ability of this population as APC revealed that they should be more aptly called plasmacytoid DC. 34 Studies in the mouse suggest that PDC are derived from the same precursor population as MDC. 24 Plasmacytoid dendritic cells circulate in human peripheral blood as CD11c -MHC class II + lineage -precursors that uniformly express high levels of IL-3Rα (CD123) and CD62L (L-selectin; Table 1 ). [35] [36] [37] Thus, IL-3, as well as CD40L, are important survival and maturation factors that promote their differentiation into APC in vitro. 34, 38, 39 Plasmacytoid dendritic Figure 1 Proposed lineage relationship and prominent surface markers on monocytes and subsets of dendritic cells (DC). Dendritic cell precursors and DC subsets at various stages of activation localize preferentially to different tissues. Lineage pathways are represented as solid arrows, and a proposed maturation pathway is indicated by the broken arrow. An inevitably incomplete list of distinguishing markers and important trafficking molecules on these different cell populations is shown as well. Markers specific to human (*) and mouse (parentheses) as indicated. HPC, hematopoietic progenitor cell; MoDC, monocyte-derived DC.
cells are thought to play a significant role both in innate defense against pathogens, and in the adaptive immune response as APC: they are the principal source of type I IFN in PBMC and tonsil, producing large amounts of IFNα in response to viral infection in vivo or in vitro; 37, 40 and following exposure to microbes become potent inducers of Th1 differentiation of reactive T cells. 41 In the mouse, PDC exist as CD11c + B220 + CD19 -Gr1 + cells in blood, bone marrow and secondary lymphoid organs. 42, 43 Similarly to their human counterparts, murine PDC appear to depend on IL-3 and CD40L for survival 42 and produce large quantities of IFNα upon viral infection. 24 Although exposure to bacterial CpG DNA and IL-3 induces T cell stimulatory capacity, low MHC class II expression on freshly isolated PDC calls into question their role in the adaptive immune response. 42 
Monocytes
Peripheral blood monocytes and tissue macrophages are both phagocytic mononuclear cells. 44 In humans, monocytes and macrophages express high levels of CD14, but in the mouse, monocytes are usually identified as CD11b + F4/80 + CD11c leucocytes. 45, 46 Monocytes develop from the common myeloid progenitor cell indicating a close lineage relationship with DC, and under certain conditions, may even differentiate into DC. 47, 48 Migratory properties of myeloid-related DC Migration of leucocytes from blood into tissues occurs via a multistep cascade of cellular interactions between circulating cells and endothelium. 49 Once in tissues, the cell's position is determined by local production of chemotactic mediators. A DC's migratory ability is intrinsically linked to its maturation state, and thus to the inflammatory microenvironment. Most information regarding DC migration into and out of tissues has come from studies using the skin as a model. The skin contains resident LC, and is arguably the most accessible organ in the body. Inflammation can be induced and monitored conveniently, and draining lymph nodes are easily identified.
Multistep cascade
In order to extravasate, leucocytes initially tether and roll along the vessel wall. Tethering and rolling are mediated by selectins or α 4 integrins, and their ligands. Engagement of chemokine receptors on rolling leucocytes by chemokines displayed on the endothelial surface then leads to a change in the conformation and/or surface distribution of integrins, resulting in increased ligand affinity and/or avidity, thus facilitating firm adherence (sticking). Once bound to the endothelial surface, cells transmigrate between adjacent endothelial cells into the surrounding tissue. The individual molecular events that make up the adhesion cascade have been mainly elucidated for neutrophils and T lymphocytes. For example, interaction of CD62L with PNAd, CCR7 with CCL21 (SLC), and possibly CCL19 (ELC), and LFA-1 with (presumably) ICAM-1 and -2, are responsible for naïve and central memory T cell adhesion in lymph node high endothelial venules (HEV). 15, [50] [51] [52] [53] Several adhesion molecules and chemokine-chemokine receptor pairs mediate organ-specific homing of effector/memory T cells. For example, CLA with CD63E (E-selectin), and CCR4 with CCL17 (TARC) or CCL22 (MDC), and CCR10 with CCL27 (CTACK) in skin; or α 4 β 7 with MAdCAM-1, and CCR9 with CCL25 (TECK) in the gut. 54 In contrast, comparatively little is known about migration of DC or monocytes from the bloodstream into tissues, either in the steady-state or under inflammatory conditions.
Dendritic cell maturation
After antigen exposure in the context of such 'danger' signals as inflammation, pathogen invasion or tissue damage, DC undergo maturation. 2, 55 This not only ensures expression of molecules relevant for T cell stimulation, but also permits DC * expressed as a heterodimer with CD11a, CD11b, CD11c or CD11d. † expressed as a heterdimer with CD49. ‡ peripheral node addressin (consisting of specialized glycoforms of GlyCAM-1, CD34, podocalyxin, sgp200). ND, not determined; MDC, myeloid-related dendritic cell; PDC, plasmacytoid dendritic cell.
to reach the appropriate anatomical compartments in secondary lymphoid organs where naïve T cells reside in large numbers. Dendritic cells can become stimulated to mature by a wide variety of pathogenic organisms, through several distinct signalling pathways. Bacteria and viruses, their related components LPS, double-stranded RNA, DNA containing CpG motifs and toxins, as well as products released by damaged cells can activate DC through Toll-like receptors (TLR), while antibody-opsonized pathogens bind Fc receptors. 10, 56 Endogenous mediators released locally in response to inflammatory stimuli, such as TNFα, IFNγ and IL-1β, as well as prostaglandins, also induce DC maturation. 57 Processing of antigen results in high-level surface expression of MHCpeptide complexes. In parallel, antigen-capturing activity is down-regulated, while expression of costimulatory molecules such as CD80, CD86 and CD40, 10 adhesion molecules for migration such as CD44 58 and α 6 β 1 integrin, 59 and T cell activation such as CD48 and CD58 are up-regulated. 18 Cognate signals via CD40L, OX40 and TNF-related activation cytokine (TRANCE) from T cells further activate DC. Activation through these different mechanisms results in a mature DC that is functionally optimized for each particular pathogenic stimulus. This occurs at the genetic level, evidenced by a recent comprehensive analysis that revealed over 1300 genes activated or suppressed by stimulation with E. coli, C. albicans, influenza virus, or their components. 60 Concomitant with DC maturation is a complete and coordinated switch in their chemokine receptor expression (Table 2 ). Immature DC express CXCR4 and CCR4, receptors for CXCL12 (SDF-1α), and CCL22 (MDC) or CCL17 (TARC), respectively. 61, 62 In addition, these DC are ideally suited for recruitment to inflammatory sites by their expression of functional receptors for inflammation-induced chemokines, such as CCR1, CCR2, CCR3, CCR5 and CXCR1. 13, 63 As mentioned above, epidermal LC also express CCR6. 31 Upon maturation, DC down-regulate expression of inflammatory chemokine receptors, while up-regulating CCR7. 12, 13 This up-regulation of CCR7 appears to involve a DAP12-mediated pathway that is activated through the triggering receptor expressed on myeloid cells (TREM)-2. 64 Thus DAP12-mutant mice demonstrate a dramatic accumulation of DC in skin and gut, as well as impaired contact sensitivity responses. 65 
Rapid recruitment of myeloid-related DC
How might DC be recruited to inflamed sites? As leucocytes, DC have to follow the same adhesion rules as described for T cells. Rapid recruitment of DC from blood into inflamed tissues is thought to be a response to the increased requirement for surveillance at the local site. 66 At such inflammatory sites, endothelial cell adhesion molecule expression is upregulated, including E-and P-selectin, VCAM-1 and L-selectin ligands, all of which can mediate leucocyte tethering and rolling. 67, 68 Using radioactive tracing techniques and confocal microscopy in vivo, immature, but not mature, bone marrowderived DC accumulated in inflamed ear skin as soon as 6 h after intravenous injection. 11, 69 Initial interactions of DC with inflamed cutaneous endothelium were mediated by E-and P-selectins. Ligands for these endothelial selectins, such as PSGL-1, require fucosylation by α1,3-fucosyltransferases (FT)-IV or -VII to achieve selectin binding. 70, 71 Whereas DC generated from FT-IV/VII-deficient mice homed poorly to inflamed skin, DC deficient only in FT-VII migrated normally. 69 Thus, FT-IV appears to be important for DC migration into inflamed skin, in contrast with T cells and neutrophils where it plays only a minor role. 70, 72, 73 The second step of the multistep cascade relies on the activation of chemokine receptors expressed on circulating DC by endothelially displayed chemokines (Table 2) . Activated endothelium can express chemokines in response to diverse inflammatory stimuli, including CCL2 (MCP-1), CCL5 (RANTES), CXCL1 (GROα), CXCL8 (IL-8) and CX3CL1 (Fractalkine). 74, 75 As described above, DC express an array of receptors for these inflammatory chemokines. 13, 76 Ligation of such chemokine receptors with chemokines displayed on endothelium triggers integrin activation and/or chemotactic migration. Upon activation by inflammatory stimuli, endothelial cells also up-regulate expression of integrin ligands such as ICAM-1, vascular cell adhesion molecule (VCAM)-1, 67 and the recently described vascular endothelial junction adhesion molecule (VE-JAM/JAM2). 77 Immature DC express appropriate ligands including LFA-1, VLA-4 and JAM3, respectively. 77, 78 However, very little is yet known about the precise mechanisms by which DC become firmly adherent within tissue microvessels, or about their subsequent diapedesis across the endothelium. In addition to expression of chemokines on the inflamed endothelium, chemokine expression within the inflamed tissues may direct DC localization after extravasation. For example, the CCR2 agonist CCL13 (MCP-4) is expressed in the basal epidermis in psoriatic lesions, and basal epithelium of inflamed tonsils. 79 CCL20 (MIP-3α) is expressed by keratinocytes in the suprabasal epidermis of psoriatic and atopic dermatitis lesions, and luminal epithelium of inflamed tonsils. 31,80,81 CCL20 activates CCR6 expressed by Langerhans cell precursors. Thus LC might be recruited to inflamed skin following a CCL20 gradient. 31 Interestingly, human CCR6 is also a receptor for β-defensins, a family of peptides released by keratinocytes upon microbial stimuli, and to which immature DC respond. 82, 83 It seems plausible that these chemokines/chemotactic peptides may act sequentially to attract recently transmigrated DC, and position them at the inflamed site.
Dendritic cells exit from tissues to lymph nodes
What are the key events in DC migration from inflamed tissues? Again, our current understanding is mainly based on studies of LC in the skin (Fig. 2) . The first step in the process of LC exit from the epidermis is the synthesis of proinflammatory mediators such as TNFα and IL-1β by keratinocytes and LC themselves in response to such inflammatory stimuli as LPS or ultraviolet light. [84] [85] [86] Other microbial products, including DNA containing signature CpG motifs, heat shock protein gp96, as well as CD40L expressed on activated T cells, have all been shown to directly trigger within DC the competence to migrate. 87 In the epidermis, LC adhere to adjacent keratinocytes via E-cadherin homophilic interactions. 88 Inflammatory cytokines reduce E-cadherin expression on DC, and stimulate actin-dependent movements, thus allowing them to leave the epidermis. 89 For this to occur, LC Figure 2 Dendritic cell (DC) migration pathways from the intestine and skin to local lymphoid tissues. Dendritic cell reside in epithelial tissues in an immature form. After contact with an inflammatory stimulus, DC undergo maturation and alter chemokine receptor expression, which facilitates their migration from the tissue into draining lymphatic vessels. In the lymph node, DC localization to the T cell area is again directed by chemokines. must cross the basement membrane at the epidermal-dermal junction, an adhesion-dependent process that involves α 6 integrins, and can be inhibited by antibodies to CD44 variant isoforms. 58, 59 Furthermore, LC express matrix metalloproteinases (MMP)-9 and -2, which may play a role in crossing the basement membrane, as well as moving within the collagenrich meshwork in the dermis, demonstrated by the inability of LC to migrate from skin explants of MMP-9-deficient mice. 90 Once in the dermis, LC must gain access to draining lymphatic vessels. Concomitant with down-regulation of inflammatory chemokine receptors is the up-regulation of CCR7, which confers lymph node homing capability on maturing DC. 31 The critical role for CCR7 ligands in DC homing was demonstrated in mice that lack CCR7, and also in plt/plt (paucity of lymph node T cells) mice that are deficient in two of the three known CCR7 ligands, CCL19 and CCL21-ser. 91, 92 The second isoform of CCL21, CCL21-leu, is expressed in lymphatic endothelium of peripheral tissues and may be involved in the exit of DC from the dermis, as MHC II + DC have been observed within CCL21 + dermal lymphatic vessels, and enhanced numbers of DC migrated from skin explants cultured ex vivo in the presence of CCL21. 93 On the other hand, CCL19 appears to be a key player in DC migration from skin to lymph nodes, since neutralizing antibodies inhibit LC migration from skin explants. 94 Dendritic cell migration from skin in response to CCL19, but not CCL21, involves the lipid transporters multidrug resistance-associated protein (MRP)-1, and multidrug resistant protein (MDR)-1, both of which are expressed by human LC. 94, 95 While both proteins transport sphingolipids, MRP-1 also mediates secretion of leukotriene (LT) C 4 . 87 Dendritic cell migration from skin was greatly reduced in MRP1-deficient mice, but restored upon injection of exogenous LTC 4 or its metabolite LTD 4 . Moreover, LTC 4 or LTD 4 were necessary for chemotaxis of DC to CCL19, but not CCL21. 94 Thus it has been proposed that through this autocrine mechanism, maturing DC sensitize themselves towards CCL19, which is also expressed by lymph vessels. 94 However, the differential mechanisms by which lymphatic CCL19 and CCL21-leu exert apparently distinct effects on migrating DC remain to be elucidated.
Other mechanisms may also play a role in DC lymph node homing. For example, osteopontin is important for inducing LC migration to lymph nodes. 96 Langerhans cells up-regulate osteopontin receptors CD44 and α V β 3 integrin upon maturation, and osteopontin-deficient mice display reduced contact sensitivity responses. Immature DC also express the α 1b -adrenergic receptor, and display chemotactic and chemokinetic responses to the neurotransmitter norepinephrine in vitro. 97 The juxtaposition of nerve fibres and LC in the epidermis further implies a potential role for neuronal inputs in directing DC migration in vivo. 98 Inside the lymph node, CCR7 ligands, CCL19 and CCL21-ser are expressed within the T cell area by stromal cells where they are thought to be important for appropriate DC localization. 99 CCL21-ser is also highly expressed by high endothelial cells. Furthermore, a subpopulation of CXCR5 + dermal DC migrates predominantly to B cell zones of the LN, where the CXCR5 ligand CXCL13 (BLC) is expressed by follicular DC. Once in the B follicle, these DC are thought to preferentially drive B cell-dependent responses. 100, 101 A number of negative regulators of LC migration from skin have been reported. Such mechanisms are thought to be physiologically important for the regulation of immune responses, but have been subverted by some microorganisms to escape immune recognition. Langerhans cell migration is enhanced in IL-10-deficient mice, suggesting a role for IL-10 in the inhibition of migration. 102 Moreover, in vitro exposure of DC to IL-10 during maturation prevented the switch from CCR6 and other inflammatory chemokine receptors to CCR7 expression. Although IL-10-treated DC retained their immature repertoire of chemokine receptors, they became incapable of migration to any inflammatory chemokines. 103 This may be important in vivo during infections, such as with Mycobacteria, in which disease progression is associated with elevated IL-10 produced by DC themselves. 104 Similarly, percutaneous Schistosoma infection leads to LC activation, but retention in the epidermis. 105 In this case, LC migration was inhibited by the action of parasite-derived prostaglandin (PG) D 2 interacting with the adenylate cyclase-coupled PGD 2 receptor on the DC. In a third example, IL-4 impeded LC mobilization by down-regulating TNF receptor-II expression. 106 While most studies of the mechanisms of DC migration to and from inflamed tissues described here have used the skin as a model, tissue specificity is known to exist with regard to T cell homing. 54 With this in mind, it may be important to investigate tissues other than skin to gain a more global picture of DC migration. In the airways of mice, DC comprise a resident network similar to LC in the skin. 107, 108 After airway challenge with bacterial, viral or soluble protein antigens, rapid recruitment of DC is observed 109,110 as well as migration of DC to draining thoracic lymph nodes with similar kinetics to those that migrate from the skin to cutaneous lymph nodes. 111 Although very little is yet known regarding the specific molecular mechanisms of homing in this model, CCR1 and CCR5 ligands have been implicated. 112 Furthermore, gut-resident DC within the intestinal mucosa have been proposed to be involved directly in the uptake of pathogenic bacteria by sampling the gut through epithelial tight junctions 113 (Fig. 2) . In this way, bacteria that lack the ability for invasion via M cells in Peyer's patches are accessible to the immune system. Dendritic cells from the gut migrate to mesenteric lymph nodes via gut-draining lymph vessels, although the mechanisms by which this occurs are largely unknown. 114, 115 
Recruitment of plasmacytoid DC to sites of inflammation
Evidence suggests that PDC are recruited to non-lymphoid organs in inflammatory conditions: rheumatoid arthritis synovial tissue (LL Cavanagh and R Thomas; unpubl. data), cutaneous lupus erythematosus 116 and sites of allergic reactions, such as allergic rhinitis. 117 In nasal allergy, PNAd is expressed on vessels in the affected tissue, as well as elevated levels of ICAM-1 and VCAM-1. 117 Interactions with these adhesion receptors are likely to be involved in DC migration into this site, as circulating PDC express the appropriate ligands, namely CD62L, β 2 and α 4 integrins, respectively. 35, 37 Moreover, PDC express CXCR3 37 the receptor for CXCL9 and CXCL10, both of which are up-regulated under inflammatory conditions. 118 Recently, PDC were observed to accumulate in human ovarian carcinoma, presumably due to high levels of the CXCR4 ligand CXCL12 produced by the tumour. 119 As the tumour-infiltrating DC expressed high levels of VLA-5 (α 5 β 1 integrin) compared to their peripheral blood precursors, this integrin may play a role in DC migration into, or retention within the tumour.
Inflammation: a setting where monocytes act as precursors of DC?
Under homeostatic conditions, it is assumed that most DC found in tissues are derived from committed blood-borne precursors. Evidence gleaned from in vitro cultures of monocytes in the presence of exogenous cytokines, namely granulocyte macrophage colony-stimulating factor (GM-CSF) and IL-4, 120 suggests that monocytes may also comprise a population of DC precursors, especially in inflammatory reactions where enhanced expression of cytokines and chemokines is found. Thus, circulating monocytes, once recruited into the inflamed tissue and having taken up antigen, may develop into DC. 48 
Rapid recruitment of monocytes in inflamed tissues
Monocytes are recruited in large numbers to inflamed tissues, and are thought to be important in the pathogenesis of some inflammatory diseases, such as atherosclerosis. 121 Preliminary in vitro analysis of monocyte interactions with activated endothelial cells under flow has identified several of the molecular pathways that may be involved in homing to inflamed tissues. Molecules mediating monocyte-endothelial cell interactions include CD62L with PNAd, PSGL-1 with CD62P (P-selectin), VLA-4 with VCAM-1 or fibronectin, and β 2 integrins with ICAM-1 expressed on monocytes and endothelial cells, respectively. [122] [123] [124] [125] In addition, secondary tethering of monocytes via L-selectin binding to PSGL-1 on adherent leucocytes might play a role in inflammation. 125 A number of mechanisms may be important for chemokine triggering of integrin activation on monocytes in inflammatory settings: CCL2-deficient mice critically depend on this chemokine for integrin activation at the inflamed site; 126 CXCL8, which is expressed at high levels in human atheroma, can also induce integrin activation resulting in monocyte adherence in vitro; 127 and interaction of CXCL1 with CXCR2 on monocytes contributed to their firm adherence to activated endothelium under flow in vitro. 128 Despite demonstrating activity in vitro, the precise role for such mechanisms in monocyte migration in vivo remains unclear.
Differentiation of monocytes into DC
Peripheral blood monocytes from humans, as well as nonhuman primates and rats, can differentiate in vitro into DC when exposed to GM-CSF plus IL-4. 120,129-132 Moreover, both human CD34
+ and murine lineage -progenitor cells undergo a similar differentiation after exposure to the same cytokines, suggesting a lineage relationship. 133, 134 Mast cells at inflammatory sites may provide a possible source for these cytokines in vivo. 135 Differentiation of monocytes into LC may involve different cytokines than for other DC. The transition of monocytes to any form of DC appears to be critically dependent on GM-CSF. However, replacement of IL-4 with IL-15 for human, or transforming growth factor (TGF)-β for mouse or human cultures, induces a DC population that expresses characteristic LC markers: CCR6, E-cadherin and langerin. 136, 137 As these cytokines are produced by keratinocytes under inflammatory conditions 138, 139 and IL-15 by DC themselves 140 this pathway of DC differentiation may be utilized, at least to some extent, in vivo. Moreover, dermal resident CD14 + cells after migration out of skin explants and culture with TGFβ (which is produced constitutively by keratinocytes) developed features of LC. 141 Monocytes have been observed to differentiate into DC without the addition of exogenous cytokines in an in vitro model of transendothelial migration. 47 At 24-48 h after initial transmigration across endothelial monolayers, some mononuclear cells migrated back across the same endothelium in a basal-to-apical direction, a process termed reverse transmigration. 142 Cells that accumulated on the apical side bore a striking resemblance to DC, phenotypically and functionally. 47 In vivo studies further suggest physiological relevance for monocytes giving rise to DC, at least in an inflammatory setting. After subcutaneous injection of latex beads, DC carrying large numbers of particles were observed in draining lymph nodes. These cells were distinct from LC, which migrated in response to topical FITC application, but did not carry beads. 48 Particle-carrying DC may normally be derived from monocytes, as very few latex bead-carrying cells were observed in lymph nodes of monocyte-deficient osteopetrotic (op/op) mice, in which monocyte-independent populations of DC are intact. 143 Although op/op mice display normal immune responses to soluble antigens, they succumb rapidly to infection with Mycobacteria. 144 In certain inflammatory conditions, such as autoimmune diseases, the local production of cytokines may play a role in the differentiation of monocytes into DC. For example, synovial fluid from rheumatoid joints that contains high numbers of DC also contains cytokines, including GM-CSF and IL-13, which in combination have been shown to be as effective as GM-CSF and IL-4 for the in vitro generation of DC from monocytes. 145 A plausible scenario to explain the abundance of DC in rheumatoid arthritis would begin with locally produced CCL5 and CCL2 in the synovial tissue, which may recruit monocytes from blood into the synovial fluid. 146 Recruited monocytes may then differentiate into DC in situ and carry antigenic material to the draining lymph nodes. Thus, perpetuation of disease may occur by providing stimulation of autoreactive effector cells, which may in turn cause further tissue damage, leading to enhanced production of monocyte chemoattractants, and so on.
Migration directly from blood to lymph nodes
Monocyte migration to lymph nodes: recruitment through HEV by 'remote control'
Although it seems that monocytes enter non-inflamed lymph nodes in limited numbers, if at all, they are recruited via HEV into inflamed lymph nodes. 147, 148 Monocytes constitutively express CD62L, α 4 and β 2 integrins, especially Mac1 (CD11b/CD18), as well as CCR2. 46 However, monocytes do not express CCR7, which is essential for T cell homing to non-inflamed lymph nodes. 50, 149 A mechanism for monocyte recruitment to lymph nodes has recently been described: a 'remote control' phenomenon, whereby a chemokine produced at a non-lymphoid inflammatory site influences the cellular recruitment into draining lymph nodes. 46,50 CCL2 (MCP-1) is produced in the skin in response to an inflammatory stimulus, and is transported from the skin via lymph to the regional lymph node. There it is transcytosed and displayed luminally on HEV. Thus expressed, CCL2 is available to signal integrin activation in rolling CCR2 + monocytes. 46 Expression of many chemokines is up-regulated during inflammation in the local lymph node including: CXCL9 (Mig), CXCL10 (IP-10), CCL3/4 (MIP-1α/β) and CCL7 (MCP-3). 150 CXCL9 expressed luminally in inflamed HEV has also been implicated in the recruitment of monocytic cells expressing CXCR3. 146, 150 Whether these CXCL9-responsive cells are monocytes, or in fact circulating DC is unclear. 147 In humans, PDC express CD62L and CXCR3, and therefore, should be able to tether and roll in lymph node HEV (via CD62L) and become stuck when encountering the CXCR3 agonist CXCL9. 37 
Can DC migrate from blood into lymph nodes?
Whereas the pathways and mechanisms described above pertain to MDC and their putative monocyte precursors, it has been speculated that PDC migrate from the bloodstream directly across HEV into lymph nodes. Under normal conditions, PDC are preferentially located in the T cell areas of secondary lymphoid organs in close proximity to HEV. 34, 37, 117 Moreover, the expression of CD62L, and CCR7 on circulating PDC 37, 63 at least in the human, should provide the molecular machinery required to cross HEV.
Recent evidence further suggests that under certain conditions there may exist a pathway whereby MDC can migrate into lymph nodes via HEV. During mammary tumour virus infection, DC are inhibited from trafficking via lymphatics to lymph nodes. Instead, DC migrate into lymph nodes draining the infected site by a L-selectin-dependent mechanism. 151 As the migrated cells were CD11b + , the potential contribution by monocytes that subsequently undergo differentiation to DC has yet to be excluded.
Migration in the steady-state
Dendritic cell migration from blood to tissues
Circulating within human blood are small numbers (less than 1% of PBMC) of HLA-DR + lineage -DC, comprising CD11c + CD123 -and CD11c -CD123 + cells in approximately equal numbers. 3, 152 After treatment of mice and humans in vivo with the pan-DC cytokine Flt3-ligand, numbers of circulating DC are vastly increased. 153, 154 In addition, peripheral tissues and secondary lymphoid organs of Flt3L-treated mice contain grossly elevated numbers of DC, due to expansion of precursors in the bone marrow. 155, 156 Furthermore, in radioactive tracing studies in animals, or in patients undergoing DC vaccination by intravenous injection, many transferred cells accumulated in spleen and non-lymphoid tissues. [157] [158] [159] Therefore it is very likely that DC are capable of migrating from the blood into peripheral tissues under homeostatic conditions.
Freshly isolated human peripheral blood DC tether and roll on E-and P-selectin in vitro. 11 These interactions are mediated by PSGL-1, in particular a carbohydrate-modified form of PSGL-1 recognized by the HECA-452 antibody, termed cutaneous lymphocyte antigen (CLA). 160 As shown by intravital microscopy, even in the absence of inflammation, significant numbers of human DC tethered and rolled in mouse ear skin microvessels in an E-and P-selectin dependent manner. 11 In humans, peripheral blood DC express high levels of other C-type lectins, such as DC-SIGN. 161 As well as mediating DC-T cell interactions via ICAM-3, DC-SIGN recognizes ICAM-2, which is expressed constitutively on vascular endothelium, and mediates both rolling and transmigration of DC in vitro. 162 With the range of chemokine receptors expressed by DC in the blood, it remains unclear which receptor/s is/are responsible for steady-state trafficking. Most information is available on the constitutive trafficking of skin-homing LC. CCR2-deficient mice have normal numbers of skin DC, implying that this chemokine receptor is not required for the migration of DC from blood. 163 On the other hand, CCR6 may be involved in LC migration into skin since a subset of peripheral blood DC (putative LC precursors) and LC express CCR6 31, 164 and CCL20 has been reported on keratinocytes in clinically normal skin. 164 However, other reports have suggested that CCR6-CCL20 interactions may be relevant only in cutaneous immunopathology, as CCL20 was found only in inflammatory skin disorders 80 and CCR6-deficient mice have normal numbers of epidermal and dermal DC. 165 It is possible that CCL20-CCR6 interactions are also important for DC homing to mucosal surfaces, as CCL20 is expressed in murine intestinal and Peyer's patch epithelium, and CCR6-expressing DC are found in close proximity. 166, 167 Moreover, MDC are absent from Peyer's patches of CCR6-deficient mice, which display impaired humoral immune responses to oral antigens. 165, 166 With integrins activated by chemokine signalling, cells may undergo firm adherence within the microvasculature. Evidence suggests that at least some DC use CD18-associated integrins for steady-state migration into the lung, as the number of DC is sharply reduced in mice lacking β 2 integrins. 168 On the other hand, the density of epidermal LC in the skin, and DC in the lungs of mice deficient in the major β 2 integrin ligand, ICAM-1, is normal. 169 Thus it is likely that some ligand redundancy exists for β 2 integrin binding, or that binding was mediated, in part, by alternative splice variants in the ICAM-1 mutant mice.
170
Constitutive DC migration from tissues to lymph nodes
While DC migration in inflammation is necessary for priming immune responses, recent evidence suggests that DC-bearing self-antigens continuously traffic from normal tissues to lymph nodes (Fig. 3) . 171 Even in the absence of inflammation, some DC are found in afferent lymph. 114 Furthermore, as the life span of most murine DC in the lung and lymphoid tissues is less than two days, DC must continuously cycle from blood to tissues to lymph nodes. 172, 173 While it remains difficult to directly visualize DC migrating from peripheral tissues to lymph nodes in the absence of inflammation, it has been proposed that this process may help to maintain peripheral tolerance by presentation of self-antigens in the absence of 'danger' signals (see below). It should be cautioned that the standard techniques used to examine migration of skin DC to draining lymph nodes inherently induce variable degrees of inflammation either by surgical trauma, or by applying various dyes or irritants onto the skin. Hence, whether results obtained by these methods truly mimic the migration of DC in the steady state remains unclear. In other systems utilizing injected antigens, DC can pick up and process these antigens from peripheral tissues, such as the airway 111,174 and intestine 175 sufficiently well to stimulate T cells in vitro. Moreover, CD11c + MHC II + DC containing melanin granules are found in skin draining lymph of mice containing an overabundance of melanocytes in the epidermis 176 and DC that migrate to mesenteric lymph nodes carry apoptotic bodies from intestinal epithelium. 115 Taken together, these findings support the view that there is a significant movement of DC from tissues to lymph nodes even in the complete absence of inflammatory stimuli.
Steady-state migration: the key for immunoregulation?
Constitutive trafficking of a small number of DC to lymph nodes might be important for keeping the immune system quiet. T cells with specificity for self-antigens are usually eliminated in the thymus during thymic selection. However, if not all self-reactivity is deleted, some of the remaining T cells can attack normal host tissues and cause autoimmunity. For this reason, a second level of control is exerted in the periphery. As DC in lymph nodes express high levels of MHC class II-self peptide complexes, 171 it has been proposed that DC in the periphery pick up self-antigens and migrate to lymph nodes to induce tolerance rather than immunity. 66 Two mechanisms have been proposed. 1 First, a specialized subset of DC may be responsible for induction of tolerance, though evidence for this remains inconclusive. 6, 177 Second, all or most DC may have the capacity to either prime or induce tolerance in T cells, but the maturation state of the DC may be critical for distinguishing between the two. 55, 178 For example, DC in lymph nodes that express large amounts of surface MHC-self-peptide complexes are relatively immature in other respects, such as low expression of costimulatory molecules. 179 This capacity of DC to form MHC-peptide complexes in absence of a maturation stimulus may then lead to tolerance. 10 Further evidence supports the view that presentation of antigen by immature DC induces tolerance, instead of antigenspecific immunity. This may be brought about via two discrete mechanisms: by deletion of self-reactive T cells, or by the induction of anergic/regulatory T cells. 1 Antigenspecific deletion of T cells was observed after targeting DC in vivo with antigen directly to CD205 (DEC-205), an endocytic receptor on DC in lymph nodes, thus allowing for antigen uptake in the absence of an inflammatory stimulus. 180 Thus stimulated, T cells were largely deleted and the mice became tolerant. In contrast, T cells stimulated in an inflammatory setting became activated. Regulatory T cells may actively suppress T cells of inappropriate specificity, such as self-antigens. 181 In human studies, repetitive stimulation of allogeneic T cells in vitro 182 or in vivo stimulation of antigenspecific T cells 183 by immature DC, and not mature DC, resulted in differentiation of regulatory T cells.
How does the capability to induce tolerance relate to the DC's migratory capability? As described, many maturation stimuli directly induce migration of tissue DC to lymph nodes. However, as discussed above, some DC migrate to lymph nodes constitutively. 171 These cells have presumably taken up antigens in the absence of overt maturation stimuli, representing a 'quiescent' state of activation. 17 Perhaps then, the nature of the antigens they carry induces migration in the absence of full maturation. During normal tissue turnover many cells die by apoptosis. Dendritic cells that selectively phagocytose apoptotic cells traffic to lymph nodes, but remain in an incompletely activated state. 55, 115, 184 It remains to be determined whether some degree of maturation, such as up-regulation of CCR7, is required for this type of migration from peripheral tissues.
Conclusion
Dendritic cells occupy a central position in the body's immune system. Not only are they critically important in the induction of immune responses against foreign and tumour antigens, but DC are also likely to be involved in the maintenance of self-tolerance in the periphery. An important factor for the DC potent role in both immunity and tolerance may be their migratory ability. As inflammation induces DC maturation and migration, DC reach the lymph nodes fully activated so that T cell priming can occur. In its absence, smaller numbers of DC migrate to lymph nodes carrying selfantigens, and therefore might induce T cell tolerance. Although much is known about DC migration under some circumstances, many open questions remain. For example, DC migrate to many different peripheral tissues; however, little is known about the specific molecular mechanisms involved. As T cells employ quite different sets of adhesion molecules to migrate to tissues such as skin and gut, this may be the case for DC as well. Furthermore, as constitutive trafficking of DC from various peripheral tissues to lymph nodes may be important for peripheral tolerance, an understanding of the mechanisms by which this occurs, and the exact nature of DC that migrate under these conditions, may be critical for the future use of DC in a plethora of immunotherapeutic strategies. Thus the conditions under which DC migrate might well be the key to their function in immunoregulation.
